Literature DB >> 6328962

99mTc red blood cell scintigraphy in evaluating focal liver lesions.

S A Rabinowitz, K A McKusick, H W Strauss.   

Abstract

To determine the accuracy of blood-pool imaging in the diagnosis of hepatic hemangiomas, 39 patients with various focal hepatic lesions were studied. The diagnoses in these patients were made by biopsy, angiography, surgical exploration, or clinical stability for a minimum of 14 months. The diagnoses were: hemangiomas (13 patients), hepatoma (three), metastases (19), abscesses (two), and liver cysts (two). After modified in vivo labeling of red blood cells with 20 mCi (740 MBq) of 99mTc pertechnetate, an initial flow study and early (1-15 min) and delayed (1-2 hr) static images were obtained. Increased blood-pool activity with a discordant flow pattern was seen in 11 of 13 patients with hemangiomas. False-negative scans occurred in two hemangiomas with extensive fibrosis. Two of three hepatomas had increased blood-pool activity associated with increased flow in a pattern identical to the increased blood-pool activity. None of the metastatic, abscess, or cystic lesions had increased blood-pool activity at any time after injection. It is concluded that 99mTc red blood cell imaging can distinguish hemangiomas from other focal liver lesions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328962     DOI: 10.2214/ajr.143.1.63

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  2 in total

1.  Is anti-alphafetoprotein immunoscintigraphy a promising approach for the diagnosis of hepatoma? Implications of a quantitative study in 41 patients.

Authors:  J L Demangeat; L Manil; C Demangeat; E Rico; C Staedel-Flaig; B Duclos; B Brunot; D Jaeck; D Bellet; A Constantinesco
Journal:  Eur J Nucl Med       Date:  1988

2.  Investigation of focal hepatic lesions: is tomographic red blood cell imaging useful?

Authors:  D C Farlow; P R Chapman; S M Gruenewald; V F Antico; G C Farrell; J M Little
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.